Six-minute walk test could help guide heart failure treatment

April 15, 2014
Six-minute walk test could help guide heart failure treatment

(HealthDay)—Distance achieved in the six-minute walk test may be a practical measure of functional capacity that guides selection of therapy for patients with heart failure, according to research published online April 9 in the Journal of the American College of Cardiology.

Daniel P. Fishbein, M.D., of Duke University in Durham, N.C., and colleagues conducted a six-minute walk test in 2,397 patients with prior to random assignment in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). The researchers assessed the association between the distance on the six-minute walk test and mortality according to treatment selection.

The researchers found that risk of mortality for with an implantable cardioverter defibrillator (ICD) versus placebo according to hazard ratio [HR] for tertiles of distance on the six-minute walk test was 0.42 (95 percent confidence interval [CI], 0.26 to 0.66) for the top tertile, greater than 386 m; 0.57 (95 percent CI, 0.39 to 0.83) for the middle tertile, 288 to 386 m; and 1.02 (95 percent CI, 0.75 to 1.39) for the bottom tertile, less than 288 m. The corresponding HRs for amiodarone therapy versus placebo were 0.68 (95 percent CI, 0.46 to 1.02) for the top tertile, 0.86 (95 percent CI, 0.61 to 1.21) for the middle tertile, and 1.56 (95 percent CI, 1.17 to 2.09) for the bottom tertile of distance on the six-minute walk test. In a secondary analysis of cause-specific mortality, ICD therapy reduced arrhythmic mortality in the top two tertiles of the six-minute walk test but had no effect on heart failure mortality.

"In summary, patients with a six-minute walk distance of less than 288 meters did not derive benefit from either prophylactic implantation or amiodarone therapy," the authors write.

Several pharmaceutical companies contributed funding to the SCD-HeFT trial.

Explore further: Interarm BP difference may up cardiac risk in diabetes

More information: Full Text (subscription or payment may be required)

Related Stories

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014
(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Nocturnal respiratory rate predicts cardiac risk after MI

March 10, 2014
(HealthDay)—Among survivors of acute myocardial infarction (MI), nocturnal respiratory rate (NRR) is significantly associated with cardiac mortality, particularly non-sudden cardiac death, according to research published ...

Clopidogrel after MI less effective in diabetes patients

September 5, 2012
(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Improved outcomes seen with ventricular assist devices

January 31, 2014
(HealthDay)—Among Medicare patients receiving implantation of ventricular assist devices (VADs) for advanced heart failure, mortality has decreased, but readmission rates did not change, according to research published ...

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014
(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

Coffee consumption linked with reduced risk of diabetes

February 17, 2014
(HealthDay)—Higher consumption of coffee is associated with lower risk of type 2 diabetes, according to research published in the February issue of Diabetes Care.

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.